News

Company News & Events

ORYZON to Present at the JMP Securities Life Sciences Conference on June 22nd, 2016

6 June 2016

BARCELONA, SPAIN and CAMBRIDGE MA.

Oryzon Genomics (Madrid Stock Exchange: ORY) (ISIN Code: ES0167733015), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative diseases, announced today that CEO Dr. Carlos Buesa will present a corporate overview at the JMP Securities Life Sciences Conference. The conference will take place on June 21 - 22, 2016 in NYC.

Click here to see the full Press Release

Posted In: 
News
Investors

Share this story